⌘K

Login Start Free

Home/Filings/4/0001123292-20-000885

4//SEC Filing

Xu Stella 4

Accession 0001123292-20-000885

CIK 0001661059other

View on SEC.gov Company Profile

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 5:47 PM ET

Size

5.2 KB

Accession

0001123292-20-000885

Insider Transaction Report

Form 4

Period: 2020-06-11

NextCure, Inc.NXTC

Director

Transactions

Award
Stock Option (Right to Buy)
2020-06-11+14,250→ 14,250 total
Exercise: $24.13Exp: 2030-06-10→ Common Stock (14,250 underlying)

Footnotes (1)

[F1]The option vests in full on the earlier of June 11, 2021 and the date of the 2021 Annual Meeting of Stockholders.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

NextCure, Inc.

CIK 0001661059

Entity typeother

Related Parties

1

filerCIK 0001728741

Filing Metadata

Form type: 4
Filed: Jun 14, 8:00 PM ET
Accepted: Jun 15, 5:47 PM ET
Size: 5.2 KB

View on SEC.gov